Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-cell Leukaemia-lymphoma

Acta Derm Venereol. 2016 Nov 2;96(7):1000-1002. doi: 10.2340/00015555-2421.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Female
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy*
  • Male
  • Middle Aged
  • Prognosis

Substances

  • Antibodies, Monoclonal, Humanized
  • mogamulizumab